黑龙江稀有血型先心病新生儿在深获救

出生仅9天的新生儿乐乐因患有完全性肺静脉异位引流（心上型）和极其罕见的CD36阴性血型，在港大深圳医院与深圳市血液中心的协作下，于8月21日成功完成高难度心脏手术1。CD36缺失型在人群中比例极低，深圳人群约为2%1，符合手术输血要求的B型CD36阴性献血者仅十余人1。

医院采取了一系列精准的预案措施以保障手术顺利。产前预警工作从2026年7月启动，通过精准基因检测锁定血型方向，随后紧急招募符合要求的稀有血型献血者1。血小板采集于8月19日完成，为手术提供了至关重要的血液保障1。由丁以群教授领衔的团队主刀进行手术，该教授从事先天性心脏病外科治疗工作30余年，在完全性肺静脉异位引流方面手术成功率居于国际领先水平1。术后患儿表现出色，仅用3小时即成功脱离呼吸机1，最终于8月26日康复出院1。

A newborn named Lele, just nine days old and diagnosed with a rare blood type (CD36 negative) and total anomalous pulmonary venous return, underwent successful cardiac surgery on August 21 at University of Hong Kong-Shenzhen Hospital with critical support from the Shenzhen Blood Center 1. The procedure required precise coordination between multiple medical disciplines to secure compatible blood products for this extremely challenging operation.

The infant presented with total anomalous pulmonary venous return in the cardiac type, complicated by the absence of CD36 antigen—a condition present in only approximately 2% of the Shenzhen population 1. The medical team faced a critical logistics challenge, as only around a dozen B-type blood donors with CD36 negative status could meet the transfusion requirements 1. To address this urgent need, the hospital initiated a prenatal warning protocol beginning in July 2026 and launched a targeted recruitment campaign to identify compatible rare blood type donors 1. Genetic testing during prenatal screening helped precisely direct the blood type search 1.

Preparation accelerated in the days immediately preceding surgery, with platelets successfully collected on August 19—just 48 hours before the scheduled operation 1. Following the procedure, the infant demonstrated remarkable resilience, successfully weaning from mechanical ventilation within three hours of surgery 1. Lele was discharged from the hospital on August 26 1. The surgical team was led by Professor Ding Yiqun, who has devoted more than 30 years to congenital heart disease surgery and maintains internationally leading success rates in total anomalous pulmonary venous return correction 1.